Due to the growing adenoma after TURP, alpha blocker
therapy may be required in the medium- to long-term, and the TURP procedure may be repeated as necessary.
Dizziness, low blood pressure, and fatigue can occur with alpha blockers
Medical expulsive therapy (MET) administered with calcium channel blockers (nifedipine) or alpha blockers
increase the chance of spontaneous passage in over 80% of cases for ureteral stones.
2) Medical treatment options include Non-Steroidal Anti-Inflamatuar Drugs (NSAIDs), alpha blockers
, steroids and calcium channel blockers.
In the ALLHAT study, diuretic drugs were compared to angiotensin-converting enzyme (ACE) inhibitors that widen blood vessels and decrease resistance, calcium channel blockers that relax vessels by slowing the flow of calcium into the heart and alpha blockers
, which also relax blood vessels.
The treatment regimen included an alpha blocker
alone in five studies (including tamsulosin in four), tamsulosin with corticosteroids in one, nifedepine alone in one and nifedepine with corticosteroids in three.
Evaluated in this trial for CP/CPPS, RAPAFLO(R) is a uniquely selective alpha blocker
approved for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), commonly referred to as an enlarged prostate.
Hypersensitivity to the particular alpha blocker
There is evidence that discontinuation of an alpha blocker
after a period of combination therapy may provide durable symptom relief.
6) Initial studies for the assessment of finasteride in combination with terazosin, doxazosin or alfuzosin were of short duration (6 months to 1 year) and failed to establish a benefit for combination therapy over placebo or alpha blocker
monotherapy in terms of symptom improvement.
First Approved Alpha Blocker
Positioned as Less Risky
A review of 53 cases of ruptured pheochromocytoma revealed that 17 (32%) of the patients died, and that no mortality occurred among the 12 patients who received an alpha blocker
(for high blood pressure) and fluid infusion therapy before surgery.
therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5-alpha reductase inhibitor dutasteride.
RAPAFLO[R] is an effective and uniquely selective alpha blocker
for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), the number one reason patients visit urologists.
Watson recently launched RAPAFLO(TM) (silodosin), the company's new alpha blocker
for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH) and GELNIQUE(TM) (oxybutynin chloride) gel 10%, the first and only topical gel for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.